Hepatitis C virus and non-Hodgkin’s lymphoma: biology, epidemiology and therapy
Abstract
Although the association between the hepatitis C virus and B-cell non-Hodgkin’s lymphomas is still controversial, there is increasing evidence of the role of this virus in several B-cell lymphoproliferative disorders, whose prototype is mixed cryoglobulinemia. The aim of the present paper was to provide an overview of the biological mechanisms involved in the development of B-cell disorders in the course of chronic hepatitis C virus infection. The link between this virus and non-Hodgkin’s lymphomas is also considered from an epidemiological point of view, and the great regional differences in the prevalence of hepatitis C-associated lymphomas are discussed. Finally, the role of antiviral therapy and suggestions about the most appropriate, currently available, therapeutic approaches are also discussed.Downloads
Download data is not yet available.

Published
2011-11-30
Keywords:
Hepatitis C virus - Mixed cryoglobulinemia - Non-Hodgkin’s lymphoma - Interferon - Ribavirin
Statistics
- Abstract views: 1406
- FULL TEXT: 211
How to Cite
Pozzato, G., Zorat, F., Bonetto, S., & Mazzaro, C. (2011). Hepatitis C virus and non-Hodgkin’s lymphoma: biology, epidemiology and therapy. Oncology Reviews, 5(4), 249–260. https://doi.org/10.4081/oncol.2011.40
Copyright (c) 2011 Gabriele Pozzato, Francesca Zorat, Stefania Bonetto, Cesare Mazzaro

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.